Glucose and lipid metabolism during long-term lisinopril therapy in hypertensive patients

Journal of Cardiovascular Pharmacology

Volumn 16, Issue 6, 1990, Pages 905-909

  Shionoiri, Hiroshi ^a   Ueda, Shin Ichiro ^a   Gotoh, Eiji ^a   Ito, Teizo ^b   Ogihara, Toshio ^c  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Mishuku Hospital   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Essential hypertension; Glucose tolerance; Lisinopril; Serum lipids

Indexed keywords

ALLOPURINOL; FUROSEMIDE; GLIBENCLAMIDE; GLICLAZIDE; ISOSORBIDE DINITRATE; LISINOPRIL; MEXILETINE; TRICHLORMETHIAZIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CHOLESTEROL; CREATININE; ENALAPRIL; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; HYPERTENSION; INSULIN; LIPIDS; LIPOPROTEINS, HDL CHOLESTEROL; LISINOPRIL; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0025689775     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199012000-00007     Document Type: Article

References (34)

1. Podolsky S, Pattavina CG. Hyperosmolar non-ketotic diabetic coma: a complication of propranolol therapy. Metabolism 1973;22:685-93.
2. Wright AD, Barber SG, Kendall MJ, Pool PH. Beta-adrenoceptor blocking drugs and blood sugar control in diabetes mellitus. Br Med J 1979;1:159-61.
3. Ames RP, Hill P. Antihypertensive therapy and the risk of coronary heart disease. J Cardiovasc Pharmacol 1982:4 (suppl 2):S206-12.
4. Groop L, Totterman KJ, Harno K, Gordin A. Influences of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus. Acta Med Scand 1982;211:7-12.
5. Kolata G. Heart study produces surprise results. Science 1982;218:31-2.
6. MRFIT (Multiple Risk Factor Intervention Trial) Research Group. Multiple risk factor intervention trial, risk factor changes and mortality results. JAMA 1982;248:1465-77.
7. Cressman MD, Vidt DG, Mohler H, Gifford RW Jr. Glucose tolerance during chronic propranolol treatment. J Clin Hypertens 1985;2:138-44.
8. Struthers AD, Murphy MB, Dollery CT. Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus. Hypertension 1985;7(suppl II): II-95-101.
9. Weinberger MH. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983;5(suppl III):III-132-8.
10. Shionoiri H, Miyakawa T, Takasaki I, et al. Glucose tolerance during chronic Captopril therapy in patients with essential hypertension. J Cardiovasc Pharmacol 1987;9:160-4.
11. Shionoiri H, Iino S, Inoue S. Glucose metabolism during Captopril mono- and combination therapy in diabetic hypertensive patients: a multiclinic trial. Clin Exp Hyperlens [A] 1987;9:671-4.
12. Malini PL, Strocchi E, Cervi V, Ambrosioni E. The metabolic effects of enalapril. Clin Exp Hypertens [A] 1987;9: 675-9.
13. Takasaki I, Shionoiri H, Hiroto S, et al. Long-term Captopril therapy with no effect on glucose metabolism in patients with essential hypertension. Am J Hypertens 1988;1:217S-20.
14. Pollare T, Lithel H, Berne C. A comparison of the effects of hydrochlorothiazide and Captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321:868-73.
15. Shionoiri H, Sugimoto K, Minamisawa K, et al. Glucose and lipid metabolism during long-term treatment with Cilazapril in hypertensive patients with or without impaired glucose metabolism. J Cardiovasc Pharmacol 1990;15:933-8.
16. Cameron HA, Higgins TJC. Clinical experience with lisinopril. Observations on safety and tolerability. J Hum Hypertens 1989;3(suppl 1): 177-86.
17. Hartman JF, Szemplinski M, Hayes NS, Keegan ME, Slater EE. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertens 1988;6: 677-83.
18. Diabetes Mellitus, Report of a WHO Study Group. Technical report series, WHO, 1985, no. 727.
19. 1) with a new microcolumn procedure. Diabetes 1978;27:931-7.
20. Castelli WP. Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am Heart J 1983;106:1191-200.
21. Amery A, Berthaux P, Bulpitt C, et al. Glucose intolerance during diuretic therapy: results of trial by the European Working Party on Hypertension in Elderly. Lancet 1978:1: 681-3.
22. Doruhorst A, Powell S, Pensky J. Aggravation by propranolol of hyperglycemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet 1985;1:123-6.
23. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham study. Arteriosclerosis 1988;8:207-11.
24. National Center for Health Statistics. Total serum cholesterol levels of adults 20 to 74 years of age: United States, 1976-1980, Vital and health statistics, Ser. II, No. 236. Department of Health and Human Services Publication (PHS) 86-1686. Washington D.C.: U.S. Government Printing Office, 1986.
25. Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki study. JAMA 1988;26:641-51.
26. Giuntoli F, Scalabrino A, Rossi A, et al. Clinical investigation on the antihypertensive and metabolic effects of Captopril in essential hypertension. Curr Ther Res 1985:38:223-30.
27. Ferriere M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J. Captopril and insulin sensitivity. Ann Intern Med 1985;102:134-5.
28. Helgeland A, Strommen R, Hagelund C, Tretli S. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. Lancet 1986:1:872-5.
29. Gambaro G, Morbiato F, Cicerello E, et al. Captopril in the treatment of hypertension in type I and type II diabetic patients. J Hypertens 1985;3(suppl 2):S149-51.
30. Sullivan PA, Kelleher M, Twomy M, Dineen M. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. J Hypertens 1985;3:359-63.
31. Yasuda G, Shionoiri H, Kubo T, Misu Y. Presynaptic angiotensin II receptors and captopril-induced adrenergic transmission failure probably not via converting enzyme inhibition in guinea-pig pulmonary arteries. J Hypertens 1987; 5(suppl 2):S39-45.
32. The 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148:1023-38.
33. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus-final report. Arch Intern Med 1987;147:830-42.
34. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Arch Intern Med 1987; 147:1165-6.